查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867588

人工心臟（TAC）全球市佔率及排名、總收入及需求預測（2025-2031年）

Total Artificial Heart - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 88 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球人工心臟市場規模預計在 2024 年達到 6.41 億美元，預計到 2031 年將達到 15.51 億美元，在 2025 年至 2031 年的預測期內，複合年成長率將達到 13.5%。

本報告對近期有關人工心臟跨境產業佈局、資本配置模式、區域經濟相互依存和供應鏈重組的關稅調整和國際戰略反制措施進行了全面評估。

經動脈人工心臟（TAH）是醫療設備，作為人工器官取代天然心臟。目前開發出多種專利人工心臟裝置，包括 Syncardia TAH、AbioCor（Abiomed，美國麻薩諸塞州丹佛斯）和 CARMAT（Carmat，法國韋利濟）。近期對這些裝置的歷史和臨床應用進行了回顧。在上述裝置中，目前僅有 Syncardia TAH 投入使用。 Carmat 目前正在進行可行性研究，但迄今為止的數據僅限於少數患者。此外，尚無關於 AbioCor 或 Carmat 用於先天性心臟疾病（CHD）患者的數據。

經動脈人工心臟（TAH）市場正經歷快速成長。這一成長主要受以下因素驅動：首先，心血管疾病發生率的上升，尤其是在老年人群中，導致終末期心臟衰竭患者數量增加。其次，心臟移植捐贈者短缺使得TAH成為可行的替代方案，尤其適用於過渡性治療。第三，TAH技術的進步，包括小型化、耐用性和可靠性的提高，使其成為臨床上可行的選擇。此外，各國政府和醫療機構對心血管疾病治療的日益重視，以及高昂治療費用的保險覆蓋範圍擴大，也促進了TAH市場的發展。

儘管前景光明，人工心臟市場仍面臨許多挑戰與風險。首先，人工心臟高成本，限制了其普及，尤其是在開發中國家。其次，長期使用人工心臟可能引發感染疾病、血栓症和機械故障等併發症，影響患者的生活品質和治療效果。第三，人工心臟植入手術複雜，需要專業的醫療團隊，術後照護也耗費大量資源。此外，長期使用人工心臟還會帶來生活方式的改變，例如行動受限和心理調整，這些都需要在患者照護中充分考慮。

隨著人工心臟瓣膜技術的日益成熟和臨床應用範圍的擴大，下游需求也日益多元化。醫院和醫療中心，尤其是心臟移植中心和加護病房，對人工心臟瓣膜的需求不斷成長。保險公司也逐漸擴大人工心臟瓣膜的承保範圍，從而提高了病患的就醫便利性。此外，患者對更高生活品質的追求，使得舒適性和便利性成為人工心臟設計和研發的關鍵考量。隨著全球人口老化和心血管疾病高發，對人工心臟的需求將持續成長，並有望在未來幾十年內成為治療心臟衰竭的關鍵組成部分。

本報告旨在對全球人工心臟市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名，並按地區/國家、類型和應用進行分析。

人工心臟市場規模估計值和預測以銷售和收入（百萬美元）為單位，以2024年為基準年，包括2020年至2031年的歷史數據和預測數據。我們運用定量和定性分析，幫助讀者制定業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並就全人工心臟做出明智的商業決策。

市場區隔

公司

  • SynCardia Systems
  • Carmat
  • Abbott Laboratories
  • Abiomed
  • Berlin Heart

按類型分類的細分市場

  • 心跳過速
  • 其他

應用領域

  • 擴張型心肌病
  • 缺血性心肌病
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Total Artificial Heart was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Total Artificial Heart cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

The Total Artificial Heart (TAH) market is experiencing rapid growth. This growth is primarily driven by several factors: first, the increasing incidence of cardiovascular diseases, particularly among the elderly population, leading to a rise in end-stage heart failure patients. Second, the shortage of heart transplant donors makes TAH an effective alternative, especially as a bridging therapy. Third, advancements in TAH technology, including miniaturization and improved durability and reliability, have made it a viable clinical option. Additionally, governmental and healthcare institutions' emphasis on cardiovascular disease treatment and insurance coverage for high-cost therapies have supported the development of the TAH market.

Despite the promising outlook, the TAH market faces several challenges and risks. First, the high cost of TAH limits its accessibility, particularly in developing countries. Second, long-term use of TAH may be associated with complications such as infections, thrombosis, and mechanical failures, impacting patient quality of life and treatment outcomes. Third, the complexity of TAH implantation surgery requires specialized medical teams, and postoperative management demands significant resources. Furthermore, the lifestyle changes required for long-term TAH use, including mobility restrictions and psychological adaptation, need to be carefully considered in patient care.

As TAH technology matures and clinical applications expand, downstream demand is becoming more diversified. Hospitals and medical centers, particularly heart transplant centers and intensive care units, are increasing their demand for TAH. Insurance companies are gradually expanding coverage for TAH, improving its accessibility for patients. Additionally, patient preferences for high-quality life have made comfort and convenience important considerations in TAH design and development. With the global aging population and the high incidence of cardiovascular diseases, the demand for TAH is expected to continue growing, establishing it as a crucial component in the treatment of heart failure in the coming decades.

This report aims to provide a comprehensive presentation of the global market for Total Artificial Heart, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Total Artificial Heart by region & country, by Type, and by Application.

The Total Artificial Heart market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Artificial Heart.

Market Segmentation

By Company

  • SynCardia Systems
  • Carmat
  • Abbott Laboratories
  • Abiomed
  • Berlin Heart

Segment by Type

  • SynCardia
  • Others

Segment by Application

  • Dilated Cardiomyopathy
  • Ischemic Cardiomyopathy
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Total Artificial Heart in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Total Artificial Heart in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Total Artificial Heart Product Introduction
  • 1.2 Global Total Artificial Heart Market Size Forecast
    • 1.2.1 Global Total Artificial Heart Sales Value (2020-2031)
    • 1.2.2 Global Total Artificial Heart Sales Volume (2020-2031)
    • 1.2.3 Global Total Artificial Heart Sales Price (2020-2031)
  • 1.3 Total Artificial Heart Market Trends & Drivers
    • 1.3.1 Total Artificial Heart Industry Trends
    • 1.3.2 Total Artificial Heart Market Drivers & Opportunity
    • 1.3.3 Total Artificial Heart Market Challenges
    • 1.3.4 Total Artificial Heart Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Total Artificial Heart Players Revenue Ranking (2024)
  • 2.2 Global Total Artificial Heart Revenue by Company (2020-2025)
  • 2.3 Global Total Artificial Heart Players Sales Volume Ranking (2024)
  • 2.4 Global Total Artificial Heart Sales Volume by Company Players (2020-2025)
  • 2.5 Global Total Artificial Heart Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Total Artificial Heart Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Total Artificial Heart Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Total Artificial Heart
  • 2.9 Total Artificial Heart Market Competitive Analysis
    • 2.9.1 Total Artificial Heart Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Total Artificial Heart Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Artificial Heart as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 SynCardia
    • 3.1.2 Others
  • 3.2 Global Total Artificial Heart Sales Value by Type
    • 3.2.1 Global Total Artificial Heart Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Total Artificial Heart Sales Value, by Type (2020-2031)
    • 3.2.3 Global Total Artificial Heart Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Total Artificial Heart Sales Volume by Type
    • 3.3.1 Global Total Artificial Heart Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Total Artificial Heart Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Total Artificial Heart Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Total Artificial Heart Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Dilated Cardiomyopathy
    • 4.1.2 Ischemic Cardiomyopathy
    • 4.1.3 Others
  • 4.2 Global Total Artificial Heart Sales Value by Application
    • 4.2.1 Global Total Artificial Heart Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Total Artificial Heart Sales Value, by Application (2020-2031)
    • 4.2.3 Global Total Artificial Heart Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Total Artificial Heart Sales Volume by Application
    • 4.3.1 Global Total Artificial Heart Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Total Artificial Heart Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Total Artificial Heart Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Total Artificial Heart Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Total Artificial Heart Sales Value by Region
    • 5.1.1 Global Total Artificial Heart Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Total Artificial Heart Sales Value by Region (2020-2025)
    • 5.1.3 Global Total Artificial Heart Sales Value by Region (2026-2031)
    • 5.1.4 Global Total Artificial Heart Sales Value by Region (%), (2020-2031)
  • 5.2 Global Total Artificial Heart Sales Volume by Region
    • 5.2.1 Global Total Artificial Heart Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Total Artificial Heart Sales Volume by Region (2020-2025)
    • 5.2.3 Global Total Artificial Heart Sales Volume by Region (2026-2031)
    • 5.2.4 Global Total Artificial Heart Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Total Artificial Heart Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Total Artificial Heart Sales Value, 2020-2031
    • 5.4.2 North America Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Total Artificial Heart Sales Value, 2020-2031
    • 5.5.2 Europe Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Total Artificial Heart Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Total Artificial Heart Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Total Artificial Heart Sales Value, 2020-2031
    • 5.7.2 South America Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Total Artificial Heart Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Total Artificial Heart Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Total Artificial Heart Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Total Artificial Heart Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Total Artificial Heart Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Total Artificial Heart Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Total Artificial Heart Sales Value, 2020-2031
    • 6.3.2 United States Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Total Artificial Heart Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Total Artificial Heart Sales Value, 2020-2031
    • 6.4.2 Europe Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Total Artificial Heart Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Total Artificial Heart Sales Value, 2020-2031
    • 6.5.2 China Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Total Artificial Heart Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Total Artificial Heart Sales Value, 2020-2031
    • 6.6.2 Japan Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Total Artificial Heart Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Total Artificial Heart Sales Value, 2020-2031
    • 6.7.2 South Korea Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Total Artificial Heart Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Total Artificial Heart Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Total Artificial Heart Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Total Artificial Heart Sales Value, 2020-2031
    • 6.9.2 India Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Total Artificial Heart Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 SynCardia Systems
    • 7.1.1 SynCardia Systems Company Information
    • 7.1.2 SynCardia Systems Introduction and Business Overview
    • 7.1.3 SynCardia Systems Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 SynCardia Systems Total Artificial Heart Product Offerings
    • 7.1.5 SynCardia Systems Recent Development
  • 7.2 Carmat
    • 7.2.1 Carmat Company Information
    • 7.2.2 Carmat Introduction and Business Overview
    • 7.2.3 Carmat Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Carmat Total Artificial Heart Product Offerings
    • 7.2.5 Carmat Recent Development
  • 7.3 Abbott Laboratories
    • 7.3.1 Abbott Laboratories Company Information
    • 7.3.2 Abbott Laboratories Introduction and Business Overview
    • 7.3.3 Abbott Laboratories Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Abbott Laboratories Total Artificial Heart Product Offerings
    • 7.3.5 Abbott Laboratories Recent Development
  • 7.4 Abiomed
    • 7.4.1 Abiomed Company Information
    • 7.4.2 Abiomed Introduction and Business Overview
    • 7.4.3 Abiomed Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Abiomed Total Artificial Heart Product Offerings
    • 7.4.5 Abiomed Recent Development
  • 7.5 Berlin Heart
    • 7.5.1 Berlin Heart Company Information
    • 7.5.2 Berlin Heart Introduction and Business Overview
    • 7.5.3 Berlin Heart Total Artificial Heart Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Berlin Heart Total Artificial Heart Product Offerings
    • 7.5.5 Berlin Heart Recent Development

8 Industry Chain Analysis

  • 8.1 Total Artificial Heart Industrial Chain
  • 8.2 Total Artificial Heart Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Total Artificial Heart Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Total Artificial Heart Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Total Artificial Heart Market Trends
  • Table 2. Total Artificial Heart Market Drivers & Opportunity
  • Table 3. Total Artificial Heart Market Challenges
  • Table 4. Total Artificial Heart Market Restraints
  • Table 5. Global Total Artificial Heart Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Total Artificial Heart Revenue Market Share by Company (2020-2025)
  • Table 7. Global Total Artificial Heart Sales Volume by Company (2020-2025) & (Units)
  • Table 8. Global Total Artificial Heart Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Total Artificial Heart Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Total Artificial Heart Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Total Artificial Heart Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Total Artificial Heart
  • Table 13. Global Total Artificial Heart Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Artificial Heart as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Total Artificial Heart Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Total Artificial Heart Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Total Artificial Heart Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Total Artificial Heart Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Total Artificial Heart Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Total Artificial Heart Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
  • Table 22. Global Total Artificial Heart Sales Volume by Type (2020-2025) & (Units)
  • Table 23. Global Total Artificial Heart Sales Volume by Type (2026-2031) & (Units)
  • Table 24. Global Total Artificial Heart Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Total Artificial Heart Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Total Artificial Heart Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Total Artificial Heart Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Total Artificial Heart Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Total Artificial Heart Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Total Artificial Heart Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Total Artificial Heart Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Total Artificial Heart Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Total Artificial Heart Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
  • Table 34. Global Total Artificial Heart Sales Volume by Application (2020-2025) & (Units)
  • Table 35. Global Total Artificial Heart Sales Volume by Application (2026-2031) & (Units)
  • Table 36. Global Total Artificial Heart Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Total Artificial Heart Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Total Artificial Heart Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Total Artificial Heart Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Total Artificial Heart Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Total Artificial Heart Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Total Artificial Heart Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Total Artificial Heart Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Total Artificial Heart Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Total Artificial Heart Sales Volume by Region (Units): 2020 VS 2024 VS 2031
  • Table 46. Global Total Artificial Heart Sales Volume by Region (2020-2025) & (Units)
  • Table 47. Global Total Artificial Heart Sales Volume by Region (2026-2031) & (Units)
  • Table 48. Global Total Artificial Heart Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Total Artificial Heart Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Total Artificial Heart Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Total Artificial Heart Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Total Artificial Heart Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Total Artificial Heart Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Total Artificial Heart Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Total Artificial Heart Sales Volume, (2020-2025) & (Units)
  • Table 56. Key Countries/Regions Total Artificial Heart Sales Volume, (2026-2031) & (Units)
  • Table 57. SynCardia Systems Company Information
  • Table 58. SynCardia Systems Introduction and Business Overview
  • Table 59. SynCardia Systems Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. SynCardia Systems Total Artificial Heart Product Offerings
  • Table 61. SynCardia Systems Recent Development
  • Table 62. Carmat Company Information
  • Table 63. Carmat Introduction and Business Overview
  • Table 64. Carmat Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Carmat Total Artificial Heart Product Offerings
  • Table 66. Carmat Recent Development
  • Table 67. Abbott Laboratories Company Information
  • Table 68. Abbott Laboratories Introduction and Business Overview
  • Table 69. Abbott Laboratories Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Abbott Laboratories Total Artificial Heart Product Offerings
  • Table 71. Abbott Laboratories Recent Development
  • Table 72. Abiomed Company Information
  • Table 73. Abiomed Introduction and Business Overview
  • Table 74. Abiomed Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Abiomed Total Artificial Heart Product Offerings
  • Table 76. Abiomed Recent Development
  • Table 77. Berlin Heart Company Information
  • Table 78. Berlin Heart Introduction and Business Overview
  • Table 79. Berlin Heart Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Berlin Heart Total Artificial Heart Product Offerings
  • Table 81. Berlin Heart Recent Development
  • Table 82. Key Raw Materials Lists
  • Table 83. Raw Materials Key Suppliers Lists
  • Table 84. Total Artificial Heart Downstream Customers
  • Table 85. Total Artificial Heart Distributors List
  • Table 86. Research Programs/Design for This Report
  • Table 87. Key Data Information from Secondary Sources
  • Table 88. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Total Artificial Heart Product Picture
  • Figure 2. Global Total Artificial Heart Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Total Artificial Heart Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Total Artificial Heart Sales Volume (2020-2031) & (Units)
  • Figure 5. Global Total Artificial Heart Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Total Artificial Heart Report Years Considered
  • Figure 7. Global Total Artificial Heart Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Total Artificial Heart Players Sales Volume Ranking (2024) & (Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Total Artificial Heart Revenue in 2024
  • Figure 10. Total Artificial Heart Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. SynCardia Picture
  • Figure 12. Others Picture
  • Figure 13. Global Total Artificial Heart Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Total Artificial Heart Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Total Artificial Heart Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
  • Figure 16. Global Total Artificial Heart Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Total Artificial Heart Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Dilated Cardiomyopathy
  • Figure 19. Product Picture of Ischemic Cardiomyopathy
  • Figure 20. Product Picture of Others
  • Figure 21. Global Total Artificial Heart Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Total Artificial Heart Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Total Artificial Heart Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
  • Figure 24. Global Total Artificial Heart Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Total Artificial Heart Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Total Artificial Heart Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Total Artificial Heart Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Total Artificial Heart Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Total Artificial Heart Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Total Artificial Heart Sales Volume (%), (2020-2031)
  • Figure 38. United States Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Total Artificial Heart Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Total Artificial Heart Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Total Artificial Heart Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Total Artificial Heart Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Total Artificial Heart Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Total Artificial Heart Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Total Artificial Heart Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Total Artificial Heart Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Total Artificial Heart Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Total Artificial Heart Industrial Chain
  • Figure 60. Total Artificial Heart Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed